| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gage L Patrick serves as a Director at CYTK. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $3.9M at current prices.
Historically, Gage L Patrick's trades have earned a below-average insider score of 45/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -32.6%.
The biggest single holding is CYTK (~$3.9M) as Director. The recent filings there lean toward selling, a net 54,523 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 26,468 | $41.33 | $1,094,023.02 | -31.4% | -14.8% | -6.7% | |
| Mar 19, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 10,000 | $24.45 | $244,468.00 | -31.5% | -11.7% | +50.1% | |
| Mar 12, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 10,339 | $21.22 | $219,371.87 | -19.2% | -11.4% | +54.4% | |
| Dec 15, 2020 | CYTK Cytokinetics Inc | Director | Sale+OE | 7,716 | $21.00 | $162,038.31 | -27.1% | - | - |